PTX-200 and Carboplatin in Ovarian Cancer
Clinical trial NCT01690468 · TERMINATED
Trial details
- NCT number
- NCT01690468
- Sponsor
- Prescient Therapeutics, Ltd.
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-01
- Primary completion
- 2019-12-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.